Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,418
Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency
Location: Seattle WA, Kansas City MO, Ft. Worth TX,
Sponsor: Altus Pharmaceuticals
Sex: All
Age: 3 - 13
Code: NCT00837863
Phase2, Recruiting
Lumbar Plexus Catheter Versus Femoral Nerve Catheter for Postoperative Pain After Anterior Cruciate Ligament (ACL) Repair
for
Postoperative Pain
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 11 - 21
Code: NCT01068275
Recruiting
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
for
Rett Syndrome
Location: Seattle WA, Philadelphia PA, Sacramento CA,
Sponsor: Biomed Industries, Inc.
Sex: Female
Age: 5 - 20
Code: NCT06840496
Phase3, Recruiting
Lake Washington Vascular VenaSeal™ Post-Market Evaluation
for
Varicose Veins, Venous Reflux
Location: Kirkland WA, Bellevue WA, Issaquah WA
Sponsor: Lake Washington Vascular
Sex: All
Age: 18+
Code: NCT04146168
Recruiting
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Tacoma WA, Kelowna, Spokane WA, Edmonton, Fair Oaks CA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Caloric Balance Markers Study
for
Metabolism
Location: Seattle WA
Sponsor: Institute for Systems Biology
Sex: All
Age: 18+
Code: NCT07141537
Not recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
for
Primary Sclerosing Cholangitis (PSC)
Location: Seattle WA, Iowa City IA, Nashville TN, Baltimore MD
Sponsor: LISCure Biosciences
Sex: All
Age: 18 - 70+
Code: NCT06699121
Phase2, Recruiting
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: Tacoma WA, Olympia WA, Eugene OR, Clovis CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase3, Recruiting
Featured
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Seattle WA, Beverly Hills CA, Denver CO, St Louis MO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06896916
Phase1, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
for
Colorectal Cancer
Location: Seattle WA, Portland OR, East Brunswick NJ,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07525206
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Seattle WA, Vancouver WA, Duarte CA, Irvine CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07155187
Phase2, Phase3, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer
Location: Seattle WA, Reno NV, Los Angeles CA, Newport Beach CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase2, Phase3, Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
for
Bipolar I Disorder, Bipolar II Disorder
Location: Everett WA, Bellevue WA, Sherman Oaks CA, Montclair CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06696755
Phase2, Recruiting
FeaturedActive & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Everett WA, Bellevue WA, Walnut Creek CA, Las Vegas NV,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase2, Recruiting
FeaturedActive & Responsive
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
for
Bipolar I or II Disorder
Location: Everett WA, Bellevue WA, Portland OR, Walnut Creek CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07220460
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Everett WA, Bellevue WA, Walnut Creek CA, Las Vegas NV,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase2, Recruiting
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
for
Solid Tumors
Location: Puyallup WA, Portland OR, Spokane WA, Los Angeles CA,